Transplantation of pancreatic beta-cell spheroids in mice <i>via</i> non-swellable hydrogel microwells composed of poly(HEMA-<i>co</i>-GelMA)-Reference-Cited by-同舟云学术

Transplantation of pancreatic beta-cell spheroids in mice via non-swellable hydrogel microwells composed of poly(HEMA-co-GelMA)

Published:2024 Issue:17 Volume:12 Page:4354-4362
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Inagaki Natsuko F.¹²^ORCID,Oki Yuichiro²,Ikeda Shunsuke³,Tulakarnwong Sarun³,Shinohara Marie³⁴^ORCID,Inagaki Fuyuki F.⁵^ORCID,Ohta Seiichi²³⁶^ORCID,Kokudo Norihiro⁵,Sakai Yasuyuki²³,Ito Taichi²³⁷^ORCID

Affiliation:

1. Department of Lipid Signaling, National Center for Global Health and Medicine, Tokyo, Japan

2. Department of Chemical System Engineering, School of Engineering, The University of Tokyo, Tokyo, Japan

3. Department of Bioengineering, School of Engineering, The University of Tokyo, Tokyo, Japan

4. Institute of Industrial Science, The University of Tokyo, Tokyo, Japan

5. Department of Surgery, National Center for Global Health and Medicine, Tokyo, Japan

6. Institute of Engineering Innovation, The University of Tokyo, Tokyo, Japan

7. Center for Disease Biology and Integrative Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan

Abstract

We developed a hydrogel microwell device for islet implantation, fabricated by crosslinking gelatin-methacryloyl (GelMA) and 2-hydroxyethyl methacrylate (HEMA).

Funder

Japan Society for the Promotion of Science

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/BM/D4BM00295D

Reference47 articles.

1. Clinical pancreatic islet transplantation

2. Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen

3. Clinical Outcomes and Insulin Secretion After Islet Transplantation With the Edmonton Protocol

4. International Trial of the Edmonton Protocol for Islet Transplantation

5. Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe Hypoglycemia